News

HIMS records subscriber surge and revenue growth in second-quarter 2025, but rising costs strain gross margins.
In separate filings, Chief Legal Officer Soleil Boughton sold 2,572 shares at a price of $51.64 apiece for $132,818, while ...
While Wall Street analysts remain cautious on Hims & Hers Health (HIMS), TipRanks’ A.I. Stock Analysis tool shows strong ...
Morgan Stanley reports that third party data point to a 20% year-over-year decline for Hims & Hers app downloads in the month of July and that ...
Doctors report insurance cuts are forcing many U.S. patients on Wegovy and Zepbound to pay high out-of-pocket costs.
Doon University-BCYW Foundation's Event Speakers Addressing the Audience. Audience Keenly Waiting to Learn from the Speakers. Speake ...
Current health news highlights include UK investor backing in Assura's acquisition by PHP, Novo Nordisk's legal affairs over Wegovy drug sales, and Apollo Hospitals' increased AI investments. The CDC ...
Weed is no longer just for hippies or hip-hop stars — around 22 million people in the U.S. are cannabis users. But there’s ...
Shedeur Sanders' NFL debut had plenty of anticipation, but it wasn't just his throws that caught fans' attention. The Cleveland Browns rookie quarterback found himself in a moment ...
Detailed price information for Gsi Technology Inc (GSIT-Q) from The Globe and Mail including charting and trades.
May 31, 2021. China's vast manufacturing sector grew at the fastest pace in eight months in May, blowing past e ...
In a Georgia courtroom that could’ve easily been heavy with nothing but pain and anger, widow Regina Johnson shocked ...